Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for the nine months ended September 30, for 2024 and 2023,...

Investview (OTCQB: INVU) Reports Positive Cash Flow for the First Time in Company History with $902,970 in the Quarter SALT LAKE CITY, UT, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Investview Corporation (OTCQB: INVU) released its first quarter financials (Form 10Q) reporting positive cash flow, increased...

SEC Compliance to Sponsor the Small-Cap Stars Spring Conference 2015 LOS ANGELES, June 8, 2015 (GLOBE NEWSWIRE) -- SEC Compliance Incorporated, the fastest growing filing agent in the United States and a leading provider of regulatory compliance solutions and printing...